Financials data is unavailable for this security.
View more
Year on year Resmed Inc grew revenues 10.95% from 4.22bn to 4.69bn while net income improved 13.75% from 897.56m to 1.02bn.
Gross margin | 56.67% |
---|---|
Net profit margin | 21.79% |
Operating margin | 28.17% |
Return on assets | 14.99% |
---|---|
Return on equity | 22.70% |
Return on investment | 17.08% |
More ▼
Cash flow in USDView more
In 2024, Resmed Inc did not generate a significant amount of cash. However, the company earned 1.40bn from its operations for a Cash Flow Margin of 29.91%. In addition the company used 269.78m on investing activities and also paid 1.12bn in financing cash flows.
Cash flow per share | 8.12 |
---|---|
Price/Cash flow per share | 29.20 |
Book value per share | 33.11 |
---|---|
Tangible book value per share | 10.46 |
More ▼
Balance sheet in USDView more
Current ratio | 2.59 |
---|---|
Quick ratio | 1.69 |
Total debt/total equity | 0.1454 |
---|---|
Total debt/total capital | 0.1269 |
More ▼
Growth rates in USD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 9.09% and 13.67%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg) | 0.81% |
---|---|
Div growth rate (5 year) | 5.34% |
Payout ratio (TTM) | 27.65% |
EPS growth(5 years) | 19.48 |
---|---|
EPS (TTM) vs TTM 1 year ago | 13.66 |
More ▼